RANI
Price
$1.12
Change
-$0.03 (-2.61%)
Updated
Apr 24 closing price
Capitalization
37.6M
12 days until earnings call
VYGR
Price
$3.53
Change
+$0.04 (+1.15%)
Updated
Apr 24 closing price
Capitalization
195.26M
18 days until earnings call
Ad is loading...

RANI vs VYGR

Header iconRANI vs VYGR Comparison
Open Charts RANI vs VYGRBanner chart's image
Rani Therapeutics Holdings
Price$1.12
Change-$0.03 (-2.61%)
Volume$303.42K
Capitalization37.6M
Voyager Therapeutics
Price$3.53
Change+$0.04 (+1.15%)
Volume$199.85K
Capitalization195.26M
RANI vs VYGR Comparison Chart
Loading...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RANI vs. VYGR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RANI is a StrongBuy and VYGR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (RANI: $1.12 vs. VYGR: $3.53)
Brand notoriety: RANI and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RANI: 159% vs. VYGR: 55%
Market capitalization -- RANI: $37.6M vs. VYGR: $195.26M
RANI [@Biotechnology] is valued at $37.6M. VYGR’s [@Biotechnology] market capitalization is $195.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RANI’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • RANI’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RANI’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • RANI’s TA Score: 5 bullish, 5 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RANI and VYGR are a good buy in the short-term.

Price Growth

RANI (@Biotechnology) experienced а -4.27% price change this week, while VYGR (@Biotechnology) price change was +11.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

RANI is expected to report earnings on Aug 07, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($195M) has a higher market cap than RANI($37.6M). RANI YTD gains are higher at: -18.248 vs. VYGR (-37.743). RANI has higher annual earnings (EBITDA): -48.72M vs. VYGR (-78.56M). VYGR has more cash in the bank: 267M vs. RANI (30.4M). RANI has less debt than VYGR: RANI (33.7M) vs VYGR (43.7M). VYGR has higher revenues than RANI: VYGR (80M) vs RANI (0).
RANIVYGRRANI / VYGR
Capitalization37.6M195M19%
EBITDA-48.72M-78.56M62%
Gain YTD-18.248-37.74348%
P/E RatioN/A6.00-
Revenue080M-
Total Cash30.4M267M11%
Total Debt33.7M43.7M77%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RANIVYGR
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XOMA24.230.89
+3.81%
XOMA Royalty Corporation
ONB20.930.37
+1.80%
Old National Bancorp
MFG4.950.08
+1.64%
Mizuho Financial Group
TORO1.890.03
+1.61%
Toro Corp
CGAU6.740.05
+0.75%
Centerra Gold

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with IMCR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then IMCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-2.61%
IMCR - RANI
34%
Loosely correlated
+1.88%
KYMR - RANI
33%
Poorly correlated
+9.32%
VYGR - RANI
33%
Poorly correlated
+1.15%
DRUG - RANI
31%
Poorly correlated
-1.99%
UBX - RANI
31%
Poorly correlated
-0.23%
More